Education
About Us
Working with TipRanks
Follow Us
Aroa Biosurgery Ltd (AU:ARX)
ASX:ARX
Total Valuation
Aroa Biosurgery Ltd has a market cap or net worth of AU$227.72M. The enterprise value is AU$132.28M.
Market CapAU$227.72M
Enterprise ValueAU$132.28M
Share Statistics
Aroa Biosurgery Ltd has 345,033,230 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding345,033,230
Owned by Insiders0.30%
Owned by Institutions―
Financial Efficiency
Aroa Biosurgery Ltd’s return on equity (ROE) is -0.04 and return on invested capital (ROIC) is -10.53%.
Return on Equity (ROE)-0.04
Return on Assets (ROA)-0.04
Return on Invested Capital (ROIC)-10.53%
Return on Capital Employed (ROCE)-0.09
Revenue Per Employee10.00T>
Profits Per Employee―
Employee Count―
Asset Turnover0.78
Inventory Turnover1.46
Valuation Ratios
The current PE Ratio of Aroa Biosurgery Ltd is ―. Aroa Biosurgery Ltd’s PEG ratio is 0.65.
PE Ratio―
PS Ratio1.90
PB Ratio1.73
Price to Fair Value1.73
Price to FCF-25.75
Price to Operating Cash Flow-101.13
PEG Ratio0.65
Income Statement
In the last 12 months, Aroa Biosurgery Ltd had revenue of 76.97M and earned -3.47M in profits. Earnings per share was -0.01.
Revenue76.97M
Gross Profit65.99M
Operating Income-8.13M
Pretax Income-2.95M
Net Income-3.47M
EBITDA2.65M
Earnings Per Share (EPS)-0.01
Cash Flow
In the last 12 months, operating cash flow was 5.73M and capital expenditures -1.13M, giving a free cash flow of 4.60M billion.
Operating Cash Flow5.73M
Free Cash Flow4.60M
Free Cash Flow per Share0.01
Dividends & Yields
Aroa Biosurgery Ltd pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.66
52-Week Price Change-8.63%
50-Day Moving Average0.71
200-Day Moving Average0.59
Relative Strength Index (RSI)40.71
Average Volume (3m)302.12K
Important Dates
Aroa Biosurgery Ltd upcoming earnings date is Nov 25, 2025, After Close (Confirmed).
Last Earnings DateMay 28, 2025
Next Earnings DateNov 25, 2025
Ex-Dividend Date―
Financial Position
Aroa Biosurgery Ltd as a current ratio of 6.62, with Debt / Equity ratio of 6.89%
Current Ratio6.62
Quick Ratio5.81
Debt to Market Cap0.00
Net Debt to EBITDA-0.54
Interest Coverage Ratio-18.49
Taxes
In the past 12 months, Aroa Biosurgery Ltd has paid 511.63K in taxes.
Income Tax511.63K
Effective Tax Rate-0.17
Enterprise Valuation
Aroa Biosurgery Ltd EV to EBITDA ratio is 54.85, with an EV/FCF ratio of -25.49.
EV to Sales1.89
EV to EBITDA54.85
EV to Free Cash Flow-25.49
EV to Operating Cash Flow-62.25
Balance Sheet
Aroa Biosurgery Ltd has AU$20.71M in cash and marketable securities with AU$6.14M in debt, giving a net cash position of AU$14.57M billion.
Cash & Marketable SecuritiesAU$20.71M
Total DebtAU$6.14M
Net CashAU$14.57M
Net Cash Per ShareAU$0.04
Tangible Book Value Per ShareAU$0.19
Margins
Gross margin is 85.74%, with operating margin of -10.56%, and net profit margin of -4.50%.
Gross Margin85.74%
Operating Margin-10.56%
Pretax Margin-3.84%
Net Profit Margin-4.50%
EBITDA Margin3.44%
EBIT Margin-2.40%
Analyst Forecast
The average price target for Aroa Biosurgery Ltd is AU$0.85, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price TargetAU$0.85
Price Target Upside32.81% Upside
Analyst ConsensusStrong Buy
Analyst Count3
Revenue Growth Forecast16.93%
EPS Growth Forecast76.47%